Related Experiment Videos

Scrapie pathogenesis in subclinically infected B-cell-deficient mice

R Frigg1, M A Klein, I Hegyi

  • 1Institutes of Neuropathology, Department of Pathology, CH-8091 Zurich, Switzerland.

Journal of Virology
|October 9, 1999
PubMed

Insights

Subclinical prion infections can occur in B-cell deficient mice, characterized by prion protein accumulation without overt disease. This study investigates the nature of this subclinical state and potential B-cell-derived neurotoxins.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Prion diseases, or transmissible spongiform encephalopathies, can exist asymptomatically.
  • B-cell deficiency in mice offers protection against prion disease following scrapie prion exposure.
  • However, a subset of these deficient mice develops subclinical prion infections.

Purpose of the Study:

  • To characterize the subclinical prion disease observed in B-cell deficient mice.
  • To explore the potential role of B-cell secreted neurotoxic factors in prion pathogenesis.

Main Methods:

  • Investigating B-cell deficient mouse models of prion infection.
  • Analyzing brain tissue for protease-resistant prion protein accumulation.
  • Assessing potential neurotoxic factors secreted by B cells.

Main Results:

  • B-cell deficient mice exhibit accumulation of protease-resistant prion protein in the brain, indicating subclinical infection.
  • The study characterized the pathological features of this asymptomatic prion state.
  • Evidence was gathered regarding the potential contribution of B-cell derived factors to disease progression.

Conclusions:

  • B-cell deficiency can lead to a subclinical form of transmissible spongiform encephalopathy, with prion protein accumulation.
  • Further research is needed to elucidate the precise mechanisms of B-cell involvement and potential neurotoxicity in prion diseases.

Related Concept Videos